MedVenture Partners

Type

Venture Capital

Status

Active

Location

Tokyo, Japan

Total investments

13

Average round size

9M

Portfolio companies

10

Rounds per year

1.30

Lead investments

3

Follow on index

0.23

Exits

1

Stages of investment
SeedEarly Stage Venture
Areas of investment
BiotechnologyHealth CareRoboticsManufacturingMedical DeviceMedicalTherapeuticsInnovation ManagementClinical TrialsFreelance

Investor highlights

Industry focus
Biotech/Life SciencesMedtech
Stage focus
Series BSeries CSeedSeries ASeries E Show 1 more

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Analytics

Total investments
13
Lead investments
3
Exits
1
Rounds per year
1.30
Follow on index
0.23
Investments by industry
  • Medical Device (10)
  • Medical (6)
  • Manufacturing (4)
  • Biotechnology (4)
  • Health Care (3)
  • Show 23 more
Investments by region
  • Canada (1)
  • Japan (9)
  • United States (3)
Peak activity year
2019

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
10
Group Appearance index
0.69
Avg. company exit year
5

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
SentiAR 11 Apr 2023 Biotechnology, Software, Health Care, 3D Technology, Medical Device, Augmented Reality Early Stage Venture 8M United States, Missouri, City of Saint Louis
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.